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As aconsequence of n byeffluents from local electronics manufacturing facilities, the
New Bedford Harbor and estuary in southeastern Massachusetts is among the sites in the United
States that are considered the most highly contaminated by polyhlorinated biphenyls (PCBs).
Since 1993, measures of intrauterine PCB exposure have been obtained for a sample ofNew
Bedford area infants. Among 122 mother-infant pairs, we identified four milk samples with total
PCB levels that were significantly her than the rest, with ested tota PCBs ranging from
1,100 to 2,400 ng/g milk fat comped with an overal mean of320 ngJg milk fat for the 122
women. The congener profile andhistory ofone case was consistent with past occupatonal PCB
exposures. Otherwise, the source of PCB exposures in these cases was difficult to specify.
Environmental exposures induding those from fish consumption were likely, whereas residence
adjacent to aPCB- _ntaminated sitewas considered an unlikelyexposure source. In all four cases,
the infantswerefili-term, healthynewborns. Because the developing nervoussystem is believedto
be particularl susceptible to PCBs (for example, prenatal PCB exposures have been a ted
withprematurity, decrements in birthweight andgestation time, andbehavioral anddevelopmen-
tal deficits in later infancyand childhood, incuding decrements in IQ), it is critical to ascein if
breast-eeding is a health risk for the women's infnts. Despite the potential for lar postnatal
PCBexposures viabreast milk there is limited evidence of ificant developmental toxicityaso-
ciated with the transmission ofmoderate PCB oncentrations through breat milk Breast-feeding
is associated with substantial health benefits including better cognitive skills among breast-fed
compared with formula-fed infants. We conclude, based on evidence from other studies, that the
benefits ofbreast-feedingprobablyoutweigh any risk from PCB exposures via breast milk among
the four New Bedford infants. In this case report, PCB analysi of breast milk and infant cord
serumwas aresearch tool. PCB analysis ofmilk is rarelydoneclinically, inpart because it is diffi
cult to use the results ofsuchanlys topredicthealth riss. Substantialeffort is needed to achieve
abetterunderstandingofthe clinical andpublichealth sigaicance ofPCB epsures,paricularly
among potentially suweptible groups such as infants and children. Such efforts are critical to
improvingthe clinicalandpublichealth management ofwdespread andongoingpopulationexpo-
suresto PCBs. Keyuwork: breastmilk, infncy, organolo PCBs,polycorinatedbiphenyhs,
prenatal exposure. Environ HedhPertc 106:513-518 (1998). [Online 14July 19981
bthp://chpneMtl.nies.nib.govldoasl1998/1 06p513-518kormick/abnsrt html
Case Presentation
As a consequence ofcontamination by efflu-
ents from local electronics manufacturing
facilities, the New Bedford Harbor and estu-
ary in southeastern Massachusetts is among
the sites in the United States that are consid-
ered the most highly contaminated by poly-
chlorinated biphenyls (PCBs). In 1979 the
contaminated estuary and harbor were dosed
to fishing and in 1982 the site was placed on
the EPA's National Priority List for haz-
ardous waste cleanup (Fig. 1). In 1993 a
studywas begun to survey levels ofintrauter-
ine PCB exposure and to assess the relation-
ship of biomarkers of intrauterine PCB
exposure to infant development among a
sample ofNew Bedford area infants. As part
ofthis ongoingwork, congener-specific PCB
concentrations and total PCB concentra-
tions are measured in serum from infant
cord blood samples collected at birth and
from maternal milk samples collected at
approximately 2 weeks postpartum. The
PCB congener profile characteristics ofthe
serum andmilksamples are also assessed.
Among 122 mother-infant pairs in
whom both breast milk and infant cord
serum samples were available, we identified
four milksamples with total PCB levels that
were significantly higher than the rest. The
summed concentrations of 49 individual
PCB congeners for these four samples ranged
from 1,100 to 2,400 ng/g milkfat, compared
with an overall mean of320 ng/g milkfat for
the 122 women. In addition, two ofthe four
samples had a distinct congener profile pat-
tern that differed noticeably from that ofthe
overall study population in their unusually
high proportion ofcongener number 28 (Fig.
2, SubjectsAand B). SubjectA's milksample
also had a high proportion ofcongener num-
ber74 (Fig. 2).
The cases associated with the four milk
samples were evaluated in detail (Table 1).
The four women were older mothers (age
>30 years). One woman had worked in
occupations associated with PCB exposure,
and two women reported eating an average
of greater than one serving per day of fish
or seafood, induding local fish for Subject
C. The fourth woman had no occupational
ordietary riskfactors for PCB exposure.
In all four cases, the infants were full-
term, healthy newborns, according to a
review of hospital birth records, the
Brazelton Neonatal Assessment (1) at birth
and age 2 weeks, and height, weight, and
head circumference measurements at birth.
No values outside accepted ranges were
found for the four infants.
Discussion
PCBs are widely occurring environmental
contaminants. Theyare afamilyof209 struc-
turally related congeners that have a common
biphenyl structure but differ in the number
and position ofchlorine substitutions. PCBs
are lipophilic, bioconcentrate in the food
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Figure 1. View of a New Bedford, Massachusetts, neighborhood adjacentto the PCB-contaminated New
Bedford harbor estuary. Notices posted along the shore advise "Warning, hazardous waste, no wading,
fishing, shelifishing per order US EPA."
Table 1. Characteristics offour New Bedford, Massachusetts, women with high breast milk polychlorinat-


































0Nonoccupationally exposed population background levels are generally<2,500 ng/g milkfat(191.
bThe mean cord serum total PCB concentration was 0.8 ng/g for the 122 New Bedford infants. There are no background standards for cord
serum PCB concentrations. On average, adult serum PCB concentrations are higherthan those in cord serum and have background levels of
upto 20ng/g (19).
chain, and are present in detectable amounts
in the fat of all human populations for
whom monitoring data are available (2).
Commercial mixtures of PCB congeners,
Aroclors, were manufactured in the United
States for almost 50 years for use as nonflam-
mable dielectrics in electronic parts, lubri-
cants, plasticizers in caulking compounds,
paints, adhesives and sealants, vehicles for
pesticide application, and pigment suspen-
sion agents in carbonless copy paper.
Commercial use ofPCBs was banned in the
United States in 1977, but because of their
resistance to degradation and metabolism
and their bioaccumulation, exposures still
occur. Dietary intake is the main source of
nonoccupational PCB exposure, particularly
from animal fat or fish harvested in contami-
nated water. PCBs readily cross the placenta,
and maternal exposures are apotential source
ofintrauterine PCB exposure. Because PCBs
are lipophilic, they concentrate in fatty tissue
induding breast milk, which in turn can be a
major source ofpostnatal PCB exposure dur-
ing infancy.
Clinical assessment ofPCB exposure risk
should include a careful occupational and
dietary history. Other potential environmen-
tal risk factors indude the condition and age
ofhousehold appliances, fluorescent lighting
fixtures, and other electrical equipment. A
history ofelectrical repair work involving old
transformers, capacitors, or other compo-
nents that may contain PCBs should be
reviewed, as should the possibility of acci-
dental or unusual exposure circumstances
(transformer fires, forexample).
Independent of exposure source, PCBs
that are commonly found in human tissue
(serum, milk, or fat, for example) are those
that are more lipophilic, are resistant to bio-
transformation, and have paraand orthosub-
stitutions-forexample, International Union
ofPure and Applied Chemists (IUPAC) (3)
congener numbers 28, 74, 99, 118, 128,
138, 153, 156, 170, and 180 (4,5) (Fig. 3).
In general, less chlorinated PCBs are more
rapidly metabolized, although half-lives of 3
and 8 years, respectively, have been estimated
for the less chlorinated PCBs 28 and 74 (6).
Estimated half-lives ofmore chlorinated con-
geners such as PCBs 138 and 153 are 16 and
28 years, respectively (4).
Exposure Assessment and
Apportionment by PCB Congener
Profiling
The concentrations of 49 individual PCB
congeners or coeluting congener pairs
(IUPAC numbers 6, 8, 18, 16, 31, 28, 33,
22, 52, 49, 44, 37, 74, 70, 66, 95, 84, 101,
99, 97, 87, 136, 77/110, 151, 135, 149,
118, 153, 105, 141, 138, 187, 183, 128,
167, 174, 177, 171, 156, 157/201, 180,
170, 199, 196/203, 189, 195, 194, 206,
209) and their sum, an estimate oftotal PCB
content, were calculated for the maternal
milk and infant cord blood samples in these
analyses, as was the congenerweight percent,
the relative contribution by weight of each
congener to the sum ofPCBs in the sample
(8). Specific patterns ofcongenerweight per-
cent have been described in association with
particular exposure sources: relatively high
prevalence ofcongeners 28 and 74 is often
associated with long-term occupational PCB
exposures (4,9), and congeners 138, 153,
and 156 may predominate in exclusively
environmental exposures (9.
The distribution of congeners in the
sample with the highest breast milk PCB
concentrations was consistent with occupa-
tional PCB exposure, which was confirmed
by history but had ceased by the time of
the study (Table 1, Fig. 2, Subject A). The
PCB congener patterns of the other three
samples were less consistent with a domi-
nant exposure source, although environ-
mental exposures including dietary expo-
sures are a likely explanation (9). Despite a
high proportion ofcongener 28 for one of
these women (Fig. 2, Subject B), none of
the women had occupational risk factors
for PCB exposure, although two were
heavy fish or seafood eaters (Table 1). PCB
excretion via prior breast-feeding,
interindividual variability in PCB metabo-
lism, the possibility of childhood expo-
sures, or other unidentified dietary or envi-
ronmental risk factors for PCB exposure
may have determined the total PCB con-
centrations and congener patterns in these
three women.
An important but difficult question in
this case is what role, ifany, residency adja-
cent to a PCB-contaminated site plays in
PCB exposures. In surveys of residents of
communities with PCB-contaminated sites,
including New Bedford, population mean
PCB concentrations have not exceeded
those of control populations (10,11). High
levels ofPCBs have only been found among
the subset of the population with occupa-
tional exposures or identifiable high risk
behaviors (fishing and consuming fish from
polluted waters, for example) (10,11).
Consistent with past surveys ofserum sam-
ples in this community, the average breast
milk PCB concentrations among the 122
New Bedfordwomen were comparable to, if
not lower than, those described in other
populations without occupational or unusu-
al dietary risk factors for PCB exposure
[Table 2 (12,13)]. The available evidence
from the current and past surveys suggests
that, in the absence ofhigh risk behaviors,
residency adjacent to a PCB-contaminated
site is unlikely to be a major contributor to
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total PCB concentrations in breast milk
among the New Bedfordwomen.
The four women identified in this report
had significantly higher milk PCB concen-
trations than the average in the New Bedford
women sampled and than the average for
other population-based samples (Table 2).
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PCB concentrations are difficult because of
differences in techniques for PCB identifica-
tion and quantification, which can account
for as much as 2- to 10-fold differences in
estimates of total PCB concentration (14).
Furthermore, in many populations, human
milk and serum PCB concentrations have
been gradually declining since the early
1980s (14,15).
With these caveats
s_ Milk W in mind, none of








ly of >6,000 ng/g
milk fat (16-18).
All of the milk
concentrations
were within pub- 128 156 180 170 lished so-called
background ranges
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oftotal PCBs ofup to approximately 2,500
ng/g milk fat (19). However, two of the
samples had higher concentrations than
were described among more recently stud-
ied (1988-1990) women in southern
Quebec, whose breast milk maximum total
PCB concentrations were approximately
1,900 ng/g milk fat (15). In addition, these
two samples exceeded the Food and Drug
Administration's (FDA) currently recom-
mended tolerance for total PCBs in com-
mercial milk of 1,500 parts per billion (fat
basis) (20). Of note, in populations sur-
veyed in the past in Michigan, up to 50%
ofbreast milkPCB concentrations exceeded
the FDAtolerance level (21).
PCB-contaminated BreastMilk as a
Health Risk
Clinical intervention, if any, in these cases
must be based on the possible health risks
associatedwiththe milkPCB concentrations.
Indeed, PCBs have wide-ranging potential
health effects including hepatotoxicity,
neurotoxicity, and immunotoxicity. PCBs
are hepatic carcinogens in experimental ani-
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Figure 2. The relative proportion by weight (congener weight percent) of 11 of the most prevalent polychlorinated biphenyl (PCB) congeners measured in New
Bedford, Massachusetts, breast milk samples. The sum of concentrations of 49 PCB congeners was used to estimate the total PCB concentration in the samples.
The mean congener weight percent profile ofthe overall population (n = 122) is compared to the profiles of samples from Subjects A, B, C, and D. Congeners are
represented using the International Union of Pure and Applied Chemists (IUPAC) numbering system (3).
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Table 2. Comparison of congener-specific breast milk polychlorinated biphenyl (PCB) concentrations
among general population samples and in four New Bedford, Massachusetts, mothers with high breast
milk PCB levels
Breast milk PCB concentration (ng/g milkfat)
Sweden Canada Holland New Bedford New Bedford
Congener" 1988-1989b 1988-1989b 1990-1992c 1993-1997d range of4high values
28 NR NR 6 10 14-380
74 NR NR NR 23 52-510
105 7 5 9 6 26-81
118 25 18 33 35 202-360
138 116 39 124 42 112-245
153 151 38 175 60 202-292
156 14 8 20 9 23-56
180 64 20 71 41 74-99
NR, notreported.
International Union ofPure andApplied Chemists (IUPAC) numbers (3).
bValues given are means orpooled sample results (12).
cValues given are medians 113).












Figure 3. The structures of 3 ofthe 49 polychlori-
nated biphenyl (PCB) congeners measured in
New Bedford, Massachusetts, breast milk sam-
ples. Congeners are represented using the
International Union of Pure and Applied Chemists
(IUPAC) numbering system (3).
mal models and are considered a probable
human carcinogen, although epidemiologic
support for their human carcinogenicity is
limited (14,22-23). With heavy exposures
characteristic ofpastoccupational oracciden-
tal exposures, PCBs have been most consis-
tently associated with skin manifestations
(e.g., chloracne) andliverfunction abnormal-
ities (19,23). Although wedid not assess liver
function, the women described here did not
present with clinical symptoms of PCB
intoxication. Had they been symptomatic,
removal from exposure would be the main
treatment. Limiting exposure to other hepa-
totoxins (medications, alcohol, chlorinated
solvents) may be useful for acute and symp-
tomatic exposures, but, except via lactation,
there is no means to promote PCB elimina-
tion (analogous to chelation for certain forms
ofmetal intoxication).
Although the mechanism is unknown,
the developing nervous system appears to
be particularly susceptible to PCB toxicities.
Thus, a critical question in the New
Bedford cases involves assessment of the
health risk of breast-feeding for the
women's infants. Substantial concern about
PCB toxicity in the developing fetus,
infants, and children resulted from acciden-
tal exposure episodes in Japan in 1968 and
Taiwan in 1979. Increased infant mortality
(24) and a congenital syndrome of low
birth weight, ectodermal defects (deformed
nails, natal teeth, and hyperpigmentation),
and developmental delay (including later
cognitive decrements and behavioral prob-
lems) was seen among children born to
mothers who ingested PCB-contaminated
cooking oil (25). However, via heat degra-
dation, the contaminated cooking oil also
contained the more potent toxins polychlo-
rinated dibenzofurans (PCDF) and poly-
chlorinated quarterphenyls (PCQs), such
that the independent effects of PCBs in
these exposures are difflcult to determine
(26). In fact, although PCB exposures were
substantial (maternal serum total PCB con-
centrations averaged 40-60 ng/g), persis-
tent cognitive decrements among exposed
children were not related to maternal PCB
levels (24).
The results ofsubsequent epidemiologic
investigations have identified PCBs as poten-
tially important human developmental tox-
ins at low exposure levels, although accep-
tance of these associations remains contro-
versial (27,28). Maternal occupational PCB
exposure has been associated with decre-
ments in birth weight and gestation time
(2*). In population-based studies, low-level
intrauterine PCB exposures have been associ-
ated with changes in fetal growth and matu-
ration (small size and short gestation, includ-
ing prematurity) (30,31) and behavioral and
developmental deficits in infancy and child-
hood, induding hypotonia and poor reflex
functioning in the neonatal period (32-34),
and decrements in visual memory at age 7
months (35), in psychomotor performance
on the Bayley Scales up to age 2 years
(36,37), in short-term memory and weight
at 4 years (38,39), and in IQ at 11 years
(40). However, some of these associations
have not been consistently demonstrated
across study cohorts, nor have they been
adjusted for potential confounding by co-
occurring potent organochlorine toxins such
as dioxin. The most consistentlydemonstrat-
ed association has been that of PCB-related
hypotonia and hyporeflexia in the newborn
period, which is of concern (23); however,
the long-term health implications of this
association are undear.
When both intrauterine PCB exposures
(estimated by maternal or infant cord serum
PCB concentrations at birth or maternal
breast milk PCB concentrations in the early
postnatal period) and postnatal PCB expo-
sures (estimated by integrating breast milk
PCB concentrations with the duration of
breast-feeding) have been assessed, these
developmental toxicities have been associat-
ed with prenatal, but not postnatal, PCB
exposures (35-40). Notable exceptions were
found in a study ofbreast-fed and formula-
fed Dutch neonates (ages 2-4 weeks) in
whom higher maternal milk PCB concen-
trations were associated with increased risk
of minor neurologic dysfunction (e.g.,
hypotonia) among breast-fed neonates after
adjustment for infant serum PCB concen-
trations at birth (13). Maternal serum and
infant serum PCB concentrations at birth
were unrelated to neurologic function.
Evaluation ofthe breast-fed infants between
3 and 18 months ofage showed an adverse
effect of postnatal PCB and dioxin expo-
sures via breast milk on psychomotor (but
not mental) Bayley Scales at 7 months but
not at 18 months, yet the breast-fed infants
did not score lower than formula-fed
infants on the Bayley Scales at any age (41).
Furthermore, the long-term significance of
these early life associations has not been
established, and the authors concluded that
theirfindings do notjustifyadvising against
breast-feeding (13,41).
There is very limited information about
the long-term consequences of PCB expo-
sures in early life. Among North Carolina
infants for whom prenatal PCB exposures
were associated with demonstrable develop-
mental decrements up to age 2 years, neither
prenatal nor postnatal PCB exposures (via
breast-feeding) were associated with perfor-
mance on McCarthy exams at 3-5 years or
school performance (assessed by grades) at
8-10 years (42). In a follow-up evaluation
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of Michigan infants at 11 years, a 6-point
decline in full-scale IQ was seen in associa-
tion with prenatal, but not postnatal, PCB
exposures (40). Specifically, children whose
mothers' initial postpartum breast milk total
PCB concentrations were .1,250 ng/g milk
fat or whose cord serum total PCB concen-
trations were .4.7 ng/g had lower IQs than
those whose maternal milk and cord serum
total PCB concentrations were <1,250 ng/g
milk fat and <4.7 ng/g, respectively. These
findings suggest that prenatal PCB expo-
sures in the New Bedford infants with the
three highest maternal milk and cord serum
PCB concentrations are potential riskfactors
for poorer cognitive performance in later
childhood. However, the findings of
Jacobson and Jacobson (40) have not been
replicated; their results were based on a
small number ofchildren (only 30 children
were in the highest exposure category), and
the most exposed children still had, on aver-
age, normal IQs. Perhaps more important,
postnatal PCB exposure, estimated by inte-
grating breast milk PCB concentrations with
duration of lactation, was not associated
with IQdecrements.
Thus, despite thepotential forlarge post-
natal PCB exposures via breast milk, there is
currently limited evidence ofdevelopmental
toxicity associated with the transmission of
low to moderate PCB concentrations
through breast milk, and the appropriate
clinical interpretation of this evidence is
unclear (43). Breast-feeding has been associ-
ated with substantial health benefits indud-
ing better cognitive skills among breast-fed
than formula-fed children (44,45). In fact,
because of the wide-ranging and substantial
health benefits of breast-feeding, the
American Academy of Pediatrics recom-
mends breast-feeding ofalmost all infants for
the first 12 months oflife, and these recom-
mendations do not include exceptions for
environmental contaminants in milk (46).
There are no accepted guidelines for breast
milk PCB concentrations that are a con-
traindication to breast-feeding. Anecdotal
case reports include recommendations
against breast-feeding in a woman with
chronic occupational PCB exposures and
breast milk PCB concentrations of 13,600
ng/g fat (14). Regulatory recommendations
for limiting dietary PCB intake to 1
pg/kg/day, for example, are problematic
because a substantial portion (up to 50% in
some populations) of breast-fed infants
exceed this limit (47,48). In part due to lim-
itations in our current knowledge, risk
assessment efforts in this area have been
unable to propose a standard and have rec-
ommended continued promotion ofbreast-
feeding (14). In the New Bedford cases, we
conclude that the benefits of breast-feeding
probably outweigh any risk from moderate
PCB exposures via breast milk. However, the
ultimate decision regarding breast-feeding
rests with mothers. When specific questions
regarding breast milk safety arise, decisions
are probably best made on an individual
basis in the context ofthe physician-patient
relationship after discussion of the known
risks and benefits.
For this case report, PCB analysis of
breast milk and infant cord serum was done
as a research tool. In fact, PCB analysis of
breast milk or infant cord serum is rarely
done clinically. These analyses are expensive,
there are no defined normal values, and, in
the absence of massive exposure and acute
toxicities, it is difficult to use the exposure
information to predict individual health
risks, as is illustrated in this case report. The
case report is also illustrative of several key
aspects ofPCB-related health risks in partic-
ular (in contrast to lead-related health risks,
for example). First, the clinical implications
of risks associated with low to moderate
perinatal PCB exposures are not well estab-
lished. Second, even where PCB-related
health risks are suspected, standardized
methods for exposure assessment are not
available. Third, except for exposure preven-
tion, there is no treatment for PCB expo-
sure. Furthermore, exposure prevention is
complicated by the long half-life of PCBs
and the fact that there is nearly universal
background exposure to these compounds.
Thus, in the absence ofclear occupational or
accidental exposures, it is often difficult to
identify major PCB exposure sources. Given
their prevalence and persistence in the envi-
ronment, PCB exposures are likely to con-
tinue for many decades. Substantial efforts
are needed to achieve a better understanding
ofthe clinical and public health significance
ofthese exposures.
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